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Dear Editor-in-Chief, 
 
Re: Breast cancer screening in a resource poor country: 
ultrasound versus mammography by Omidiji O.A.T, 
Campbell P.C, Irurhe N. K, Atalabi O.M and Toyobo 
O.O Ghana Med J 2017;51(21):6-12  
DOI: http://dx.doi.org/10.4314/gmj.v51i1.2 
 
We have read the article entitled “Breast cancer screen-
ing in a resource poor country: ultrasound versus mam-
mography1, published in the Ghana Medical Journal 
(2017; 51 (1): 6–12). We want to congratulate the au-
thors for this successful article, and make some contri-
butions.  
 
In the article it has been indicated that the sensitivity of 
ultrasound compared with mammography in the detec-
tion of breast lesion was 100%. However, the systematic 
random sampling technique of selection for the 300 
patients was not described. Seven women had ductal 
carcinoma in-situ (DCIS) and one invasive ductal carci-
noma (IDC). This very high prevalence of DCIS or IDC 
in women predominantly 30-39 years of age represents 
a very high prevalence of disease strongly suggestive of 
major selection bias. In addition, not all DCIS progress-
es to invasive breast cancer and it is only the sensitivity 
to detect invasive breast cancer that can be used to pre-
dict the impact of screening. There were too few women 
with DCIS or invasive cancer to enable precise 
measures of sensitivity to be calculated. The authors did 
not make clear whether verification of the results of the 
index texts was performed using a gold standard and 
whether this was done for all subjects. If disease status 
is not ascertain for all study subjects, verification bias 
may occur which can result in overestimation or under-
estimation of the sensitivity of ultrasound. The authors 
have also failed to mention that the lower sensitivity 
reported for mammography might be due to the high 
proportion of younger women included in the study 
since ultrasound is mostly complementary to mammog-
raphy for dense breasts which is common in younger 
women. There is little evidence to support the use of 
ultrasound as the first line of screening tool for breast 
cancer in rural areas.  
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Response by authors: 
 
Thank you so much for your interest and thorough eval-
uation of our article. 
 
A minimum sample size of 300 was calculated using the 
Buderer’s formula for sensitivity. Every second eligible 
patient who met the inclusion criteria was recruited into 
the study. The first participant was selected by balloting 
and every second participant selected until the desired 
number was reached.  
 
The participants were randomly selected and results 
documented as shown. Moreover studies have shown 
that the awareness of younger women about breast can-
cer has increased and perhaps may cause them toseek 
more medical attention compared with the older age 
group due to breast cancer campaigns in schools, market 
places and religious organizations. 
 
DCIS is also referred to as early breast cancer and is 
treated by surgery, radiation and chemotherapy (tamoxi-
fen) to prevent it from becoming invasive. In our centre, 
mastectomy is the surgical procedure of choice rather 
than lumpectomy, hence our inclusion of the cases in 
the data. 
 
This was noted in our earlier write-ups as a limitation. 
We agree that the cases were few but we had to work 
with the figures we had. We are however planning a 
larger scale, multicenter study that will perhaps give a 
more precise measure. 
 
Majority of the participants however had normal index 
tests with no lesion to biopsy. Others had obviously 
benign lesions such as breast cysts. Our standard in our 
hospital is that only suspicious lesions (BIRADS 3 and 
above) are subjected to the gold standard (histology). 
The index tests are taken as gold standard with normal 
or benign lesions. 
 
The study does appear skewed toward the 30 – 39 age 
group, however as noted in the study, fatty parenchyma 
(BIRADS A and B) predominated across all age groups. 
This has also been noted in other African studies, as 
discussed in the article. Majority of the women who had 
breast cancer in the 30 – 39 age group also had fatty 
breasts, as shown in the Table 4.  
 
As mentioned earlier, studies are underway to assess 
more women in the older age group using both ultra-
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Based on our findings, there is some evidence. The find-
ings may not be generalized, as a much more large sam-
ple size is required and better still if a multicenter ap-
proach is done. This is however a preliminary study and 
a multicenter study with a larger sample size may alter 
the findings in the study. The findings are however use-
ful for our local use and further studies are on going. 
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